tiprankstipranks
Trending News
More News >
Pharmaust Limited (DE:ECQ0)
FRANKFURT:ECQ0
Germany Market

Pharmaust Limited (ECQ0) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Pharmaust Limited’s (ECQ0) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Pharmaust Limited is a Buy.
Pharmaust Limited’s (ECQ0) 20-Day exponential moving average is 0.07, while Pharmaust Limited’s (ECQ0) share price is <€0.1, making it a Sell.
Pharmaust Limited’s (ECQ0) 50-Day exponential moving average is 0.07, while Pharmaust Limited’s (ECQ0) share price is <€0.1, making it a Buy.

Pharmaust Limited (ECQ0) Pivot Points

Jun 04, 2025, 02:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.07
0.07
0.07
0.07
0.07
0.07
Fibonacci
0.07
0.07
0.07
0.07
0.07
0.07
0.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaust Limited (ECQ0) Moving Averages

Jun 04, 2025, 02:13 PM
Period
Simple
Exponential
MA5
0.07Sell
0.07Sell
MA10
0.07Sell
0.07Sell
MA20
0.07Sell
0.07Sell
MA50
0.06Buy
0.07Buy
MA100
0.07Sell
0.07Sell
MA200
0.08Sell
0.08Sell
Pharmaust Limited’s (ECQ0) 10-Day exponential moving average is 0.07, while Pharmaust Limited’s (ECQ0) share price is <€0.1, making it a Sell.
Pharmaust Limited’s (ECQ0) 100-Day exponential moving average is 0.07, while Pharmaust Limited’s (ECQ0) share price is <€0.1, making it a Sell.
Pharmaust Limited’s (ECQ0) stock price is <€0.1 and Pharmaust Limited’s (ECQ0) 50-day simple moving average is 0.06, creating a Buy signal.
Pharmaust Limited’s (ECQ0) stock price is <€0.1 and Pharmaust Limited’s (ECQ0) 100-day simple moving average is 0.07, creating a Sell signal.
Pharmaust Limited’s (ECQ0) stock price is <€0.1 and Pharmaust Limited’s (ECQ0) 200-day simple moving average is 0.08, creating a Sell signal.

Pharmaust Limited (ECQ0) Technical Indicators

Jun 04, 2025, 02:13 PM
Name
Value
Implied Action
RSI (14)
49.65
Neutral
STOCH (9,6)
6.47
Buy
STOCHRSI (14)
6.47
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
45.32
Neutral
Williams %R
-87.50
Buy
CCI (14)
-84.93
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
65.82
Neutral
ROC
0.00
Buy
Pharmaust Limited’s (ECQ0) Relative Strength Index (RSI) is 49.65, creating a Neutral signal.
Pharmaust Limited’s (ECQ0) Trend Strength Indicator (ADX) is 45.32, creating a Neutral signal.
Pharmaust Limited’s (ECQ0) Commodity Channel Index (CCI) is -84.93, creating a Neutral signal.

FAQ

Is ECQ0 a Buy, Hold, or Sell?
Based on ECQ0’s technical indicators, ECQ0 is a Sell.
    What is ECQ0’s RSI (14)?
    ECQ0’s RSI (14) is 49.65, which suggests ECQ0 is a Neutral.
      What is ECQ0’s MACD?
      ECQ0’s MACD is <0.01, which suggests ECQ0 is a Buy.
        What is ECQ0’s 5-day moving average?
        ECQ0’s 5-day moving average is 0.07, which suggests ECQ0 is a Sell.
          What is ECQ0’s 20-day moving average?
          ECQ0 20-day moving average is 0.07, which suggests ECQ0 is a Sell.
            What is ECQ0’s 50-day moving average?
            ECQ0’s 50-day moving average is 0.06, which suggests ECQ0 is a Buy.
              What is ECQ0’s 200-day moving average?
              ECQ0’s 200-day moving average is 0.08, which suggests ECQ0 is a Sell.
                What is ECQ0’s Williams % R (14)?
                ECQ0’s Williams % R (14) is -87.50, which suggests ECQ0 is a Buy.
                  What is ECQ0’s CCI (14)?
                  ECQ0’s CCI (14) is -84.93, which suggests ECQ0 is a Neutral.
                    What is the share price of Pharmaust Limited?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis